PlexBio Co., Ltd.: Difference between revisions
(Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers automated DNA and RNA sample preparation extraction kits; IntelliPlex platform that is designed for precision image code MicroDisc (pCode) technology with for sample-to-answer multiplexing assays; oncology kits for lung cancer and mutation detection, as well as rearrangements; IntelliPlex SARS-Co...") |
(No difference)
|
Latest revision as of 00:39, 27 September 2022
Summary[1]Edit
PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers automated DNA and RNA sample preparation extraction kits; IntelliPlex platform that is designed for precision image code MicroDisc (pCode) technology with for sample-to-answer multiplexing assays; oncology kits for lung cancer and mutation detection, as well as rearrangements; IntelliPlex SARS-CoV-2 detection test kits/flu kits and IntelliPlex SARS-CoV-2 variant analysis kits; and pCode coupling buffer sets. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan.
References and notesEdit
- ↑ Source: Yahoo Finance.